Imperative Care, Inc.

Imperative Care, Inc. is a medical technology company dedicated to developing innovative solutions for patients suffering from thromboembolic disease, including stroke and other devastating vascular conditions. The company's core mission is to address existing gaps across the entire patient journey to elevate the standard of care. Founded in 2015 by serial medtech entrepreneur Fred Khosravi and pioneering endovascular neurosurgeon Dr. L. Nelson (Nick) Hopkins, Imperative Care is headquartered in Campbell, California.

The company's product portfolio focuses on neurovascular and peripheral vascular interventions. Key offerings include the Zoom Stroke System, which provides comprehensive solutions for ischemic stroke treatment, and the Symphony® Thrombectomy System and Prodigy® Thrombectomy System, designed for treating venous thromboembolism and acute limb ischemia, respectively. Imperative Care also offers a sterile-field clot capture and vacuum pump system and is actively developing the Telos robotic platform, an endovascular robotic system intended to enhance procedural precision and expand access to life-saving treatments.

Imperative Care is a privately held company led by Chairman and CEO Fred Khosravi, with Chuck Alpuche serving as President and Chief Operating Officer. In March 2026, the company secured an oversubscribed $100 million convertible note financing round, co-led by Elevage Medical Technologies and Perceptive Advisors, to further support the commercialization of its existing products and the advancement of its Telos robotic platform. Additionally, in July 2026, Imperative Care launched the Ikon™ 24 Pro Guidewire, a next-generation neurovascular guidewire designed to improve vascular access and enhance the efficiency of stroke procedures within its Zoom Stroke System. The company has raised approximately $596 million in total funding across various rounds.